May 26, 2025, 10:22

Experimental Therapeutics Clinical Fellowship – National Cancer Centre Singapore

This 12-month fellowship provides comprehensive training in early-phase (Phase I) oncology trials and drug development. Fellows will gain hands-on experience in managing patients enrolled in first-in-human studies and be immersed in precision oncology, translational research, clinical trial design, and multidisciplinary care. The program also focuses on teaching and psycho-social care of patients.

Eligibility Criteria:

MBBS and registration as a medical doctor in home country
Proficient in English
Completed basic training in Internal Medicine; MRCP or local equivalent preferred
Preferred: Enrollment in medical oncology training and interest in translational research
Not out of clinical practice for more than 3 years
For the funded Phase I/Thoracic Fellowship, candidates must be eligible for a medical license in Singapore and show interest in drug development and thoracic oncology

Funding Details:

One funded fellowship position is available annually at the Experimental Cancer Therapeutics Unit
Support includes research training, clinical exposure, and potential engagement with international trialists and industry

Duration: 12 months

Deadline: Rolling applications (subject to availability and selection)

Further Information:

Email: [email protected]

Visit: SingHealth Fellowship Programmes

cancer cancer therapeutics early phase trials Experimental Therapeutics MRCP National Cancer Centre Singapore NCCS OncoDaily Oncology oncology drug development oncology fellowship phase I trials Precision Oncology Singapore SingHealth Thoracic Oncology translational research

Cyril Konto: I Trademarked The Word ‘Multispecific’ The Day I Arrived

Levi Garraway: Transforming Oncology Through Precision, Resilience And Heart

20 Posts Not to Miss from ASCO 2025

Jessie J Diagnosed with Early-Stage Breast Cancer: What Is the Prognosis?

Robin Zon: The Official End of My Term as ASCO President